These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35697536)

  • 41. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database.
    Durrieu G; Maupiler M; Rousseau V; Chebane L; Montastruc F; Bondon-Guitton E; Montastruc JL
    Paediatr Drugs; 2018 Feb; 20(1):81-87. PubMed ID: 28766184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
    Shehab N; Lewis CL; Streetman DD; Donn SM
    Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
    Abrantes CG; Duarte D; Reis CP
    J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database.
    Lacroix I; Hurault C; Sarramon MF; Guitard C; Berrebi A; Grau M; Albouy-Cossard C; Bourrel R; Elefant E; Montastruc JL; Damase-Michel C
    Eur J Clin Pharmacol; 2009 Aug; 65(8):839-46. PubMed ID: 19365629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database.
    Soussan C; Gouraud A; Portolan G; Jean-Pastor MJ; Pecriaux C; Montastruc JL; Damase-Michel C; Lacroix I
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1361-6. PubMed ID: 25183382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?
    Hurault-Delarue C; Chouquet C; Savy N; Lacroix I; Beau AB; Montastruc JL; Damase-Michel C
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):770-7. PubMed ID: 27018245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version.
    Salunke S; Brandys B; Giacoia G; Tuleu C
    Int J Pharm; 2013 Nov; 457(1):310-22. PubMed ID: 24070789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Excipient exposure in very low birth weight preterm neonates.
    Akinmboni TO; Davis NL; Falck AJ; Bearer CF; Mooney SM
    J Perinatol; 2018 Feb; 38(2):169-174. PubMed ID: 29095430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of ethanol and other potentially harmful excipients in pediatric oral medicines: survey of community pharmacies in a Nigerian City.
    Soremekun R; Ogbuefi I; Aderemi-Williams R
    BMC Res Notes; 2019 Jul; 12(1):460. PubMed ID: 31349864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database.
    Pierson-Marchandise M; Gras V; Moragny J; Micallef J; Gaboriau L; Picard S; Choukroun G; Masmoudi K; Liabeuf S;
    Br J Clin Pharmacol; 2017 Jun; 83(6):1341-1349. PubMed ID: 28002877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drugs and retinal disorders: A case/non-case study in the French pharmacovigilance database].
    Bourgeois N; Chavant F; Lafay-Chebassier C; Leveziel N; Pérault-Pochat MC
    Therapie; 2016 Sep; 71(4):365-74. PubMed ID: 27203167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential pharmacokinetic interaction between orally administered drug and osmotically active excipients in pediatric polypharmacy.
    Matsui K; Nakagawa T; Okumura T; Yamane M; Tokunaga Y; Yokota S
    Eur J Pharm Sci; 2021 Oct; 165():105934. PubMed ID: 34256099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The French Pregnancy Cohort: Medication use during pregnancy in the French population.
    Bérard A; Abbas-Chorfa F; Kassai B; Vial T; Nguyen KA; Sheehy O; Schott AM
    PLoS One; 2019; 14(7):e0219095. PubMed ID: 31314794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drugs and Sleep Apneas? A review of the French Pharmacovigilance database.
    Linselle M; Montastruc F; Jantzen H; Valnet-Rabier MB; Haramburu F; Coquerel A; Gouraud A; Perault-Pochat MC; Bagheri H; Montastruc JL
    Therapie; 2015; 70(4):347-50. PubMed ID: 25679185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France.
    Bénard-Laribière A; Noize P; Girodet PO; Lassalle R; Dureau-Pournin C; Droz-Perroteau C; Fourrier-Réglat A; Salvo F; Bezin J; Pariente A;
    Therapie; 2019 Sep; 74(4):469-476. PubMed ID: 30857740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.
    Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
    Fundam Clin Pharmacol; 2014 Apr; 28(2):230-5. PubMed ID: 23190210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knowledge and practices of pregnant women in relation to the intake of drugs during pregnancy.
    Rizk MA; Abdel-Aziz F; Ashmawy AA; Mahmoud AA; Abuzeid TM
    J Egypt Public Health Assoc; 1993; 68(5-6):567-91. PubMed ID: 7775881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The general practitioner's knowledge and attitude towards proton pump inhibitors adverse effects].
    Rudelle K; Laroche ML
    Therapie; 2020; 75(3):253-260. PubMed ID: 31471066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.